Globus Medical, Inc. (GMED) NYSE
81.88
-0.57(-0.69%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
81.88
-0.57(-0.69%)
Currency In USD
| Previous Close | 82.45 |
| Open | 82.61 |
| Day High | 82.76 |
| Day Low | 81.57 |
| 52-Week High | 101.4 |
| 52-Week Low | 51.79 |
| Volume | 1.55M |
| Average Volume | 1.34M |
| Market Cap | 11.04B |
| PE | 19.13 |
| EPS | 4.28 |
| Moving Average 50 Days | 87.2 |
| Moving Average 200 Days | 79.64 |
| Change | -0.57 |
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
GlobeNewswire Inc.
Feb 12, 2026 9:30 PM GMT
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close o
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
GlobeNewswire Inc.
Oct 14, 2025 8:40 PM GMT
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to addre
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
GlobeNewswire Inc.
Aug 28, 2025 8:30 PM GMT
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against